"Worldwide Clinical Trials is a customer-centric Contract Research Organization (CRO) with over 30 years of experience of fostering the development of life-changing medicines by integrating clinical trial methodology, operational acumen, and efficient technology."

During the past decade, Worldwide Clinical Trials conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 8 clinical trials were completed, i.e. on average, 19% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 7 clinical trials were completed. i.e. 29.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Worldwide Clinical Trials" #1 sponsor was "Daiichi Sankyo, Inc." with 8 trials, followed by "Eisai Inc." with 5 trials sponsored, "USWM, LLC (dba US WorldMeds)" with 5 trials sponsored, "Global Alliance for TB Drug Development" with 3 trials sponsored and "Daiichi Sankyo Co., Ltd." with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Worldwide Clinical Trials" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 5 trials as a collaborator, "Worldwide Clinical Trials" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "H3 Biomedicine Inc." with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Worldwide Clinical Trials" are "Healthy Subjects" (6 trials), "Healthy Volunteer" (6 trials), "Pharmacokinetics" (6 trials), "Healthy" (5 trials) and "Healthy Volunteers" (5 trials). Many other conditions were trialed in "Worldwide Clinical Trials" in a lesser frequency.

Most popular intervention types in "Worldwide Clinical Trials" are "Drug" (46 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "DS-8500a" (2 trials), "Lofexidine hydrochloride" (2 trials), "Nalmefene Hydrochloride" (2 trials) and "Quizartinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Worldwide Clinical Trials" are 44 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Worldwide Clinical Trials". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Worldwide Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Worldwide Clinical Trials, 43 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".